Advertisement
Database analysis sets stage for a multicenter trial assessing TAVR’s potential role
1,000-patient prospective trial to start enrolling patients soon
PARTNER 2 analysis finds few significant effects
PARTNER 3 and CoreValve Low Risk reveal pros and cons of both approaches
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Pathophysiologic understanding and deep experience with BAV are invaluable
Review says there’s too much data variance to know
Experts weigh in on proposed changes to reimbursement requirements
Worsening RV function portends poorer prognosis regardless of procedure type
Cleveland Clinic among first users of the Inspiris Resilia valve
Matched cohort study finds marked survival disadvantage with radiation
Advertisement
Advertisement